AKTS institutional ownership changes in Q2 2026: 48 institutions opened or added positions, 17 trimmed or exited. AKTS (Aktis Oncology, Inc.) is held by 68 institutional investors as of Q2 2026. Top institutional shareholders: BlackRock, Inc. ($73.4M), Wellington Management Group LLP ($63.4M), RTW Investments, LP ($51.3M). Institutions were buying, on balance.
Who's Trading
Latest move
Source dates: Price Nov 6, 2026 · Insiders Sep 24, 2026 · Activists May 14, 2026 · Congress none
Top Holders
Showing 1-20 of 72
Continue exploring
Questions investors ask about AKTS
Who owns AKTS?
68 institutional investors held AKTS on June 30, 2026, led by BlackRock, Inc. ($73.4M), Wellington Management Group LLP ($63.4M) and RTW Investments, LP ($51.3M).
How many hedge funds hold AKTS?
68 institutional investors reported AKTS in their 13F filings for the quarter ended June 30, 2026, $479.9M in all. 2 of them are rated Elite.
Are institutions buying or selling AKTS?
Buying, on balance. In Q2 2026, 48 institutions opened or added to positions in AKTS and 17 institutions trimmed or exited.
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer
